Myoguide Needle EMG-guided Injection System Satisfies IEC/TUV Testing

31/10/2010 Intronix Technologies Corporation

Toronto, Ontario, October 31 2010 – Intronix Technologies has just had an IEC/TUV testing program completed on Myoguide, needle EMG guided injection system. Testing to TUV (c-us) mark to IEC/CSA/UL/60601-1, IEC 60601-1-2 – EMC standards, and IEC 60601-2-40 – “EMG” standards, has been completed, including a successful on-site inspection.

Intronix Technologies maintains a firm commitment quality and adherence to international regulatory requirements.

Our quality system is registered to both ISO 9001:2008 and ISO 13485:2003. BSI is our quality systems registrar accredited under the Canadian Medical Devices Conformity Assessment System (CMDCAS).

Intronix Technologies Corporation will show their “new and improved” needle EMG (electromyography) guided injection system, Myoguide, at MEDICA 2010, November 17-20, in Düsseldorf, Germany.

To see how it works, or simply for more information on Myoguide, and the new Myoguide DOC, please visit us at MEDICA 2010 Düsseldorf, Germany: Hall #16, Booth # G42 (Ontario-Canada Pavilion), November 17-20, 2010.

For more information:
Dr. Evan Friedman
President, Intronix Technologies Corporation,
drevan@intronixtech.com
+01-905-951-3361
www.intronixtech.com